Full data view for gene TSC1

The curator’s expert opinion on the classification of a variant, can be found in the
SUMMARY record. Regarding the classification, please note that where there are several
records of the same variant, the classification of that variant may differ depending on the
submitter’s conclusion.
Information The variants shown are described using the NM_000368.4 transcript reference sequence.

5 entries on 1 page. Showing entries 1 - 5.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Predict-BioInf     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+/. 15 c.1530_1531del r.(?) p.(Asp510Glufs*24) - - Unknown - pathogenic (dominant) g.135781435_135781436del g.132906048_132906049del 1750delCA - TSC1_000097 2bp deletion of CA (according to HGVS nomenclature) described as deletion of AC PubMed: van Slegtenhorst, 1997, PubMed: Young, 1998 - - Germline - 2/2 individuals tested have the variant HpyCH4III- - - DNA SSCA Blood - TSC - PubMed: van Slegtenhorst, 1997, PubMed: Young, 1998 small family ? - - - - - - - 2 Rosemary Ekong
+/. 15 c.1530_1531del r.(?) p.(Asp510Glufs*24) - - Unknown - pathogenic (dominant) g.135781435_135781436del g.132906048_132906049del c.1530_1531delCA, p.Asp510Glufs*24, exon 15 - TSC1_000097 2bp deletion of CA; sequence analysis and deletion/duplication testing performed on multiple genes (VHL, NF1, TSC1, TSC2, SMAD4, BMPR1A, PTEN, STK11, GREM1, POLD1, POLE); no other pathogenic variant found PubMed: Mortaji, 2017 - - Unknown - - HpyCH4III- - - DNA SEQ Blood - ? - PubMed: Mortaji, 2017 TSC affected 35-year-old with history of depression, anxiety, insomnia, and obesity; later diagnosed with TSC and pancreatic neuroendocrine tumor; her daughter has multiple SENs, hypopigmented macules and rhabdomyomas; not reported if daughter tested F - United States - - - - - 1 Rosemary Ekong
+/+ 15 c.1530_1531del r.(?) p.(Asp510Glufs*24) - - Unknown - pathogenic (dominant) g.135781435_135781436del g.132906048_132906049del - - TSC1_000097 2bp deletion of CA - - - SUMMARY record - - - - - - - - - - - - - - - - - - - - - - -
+/. 15 c.1530_1531del r.(?) p.(Asp510Glufs*24) - - Unknown ACMG pathogenic (dominant) g.135781435_135781436del g.132906048_132906049del - - TSC1_000097 - PubMed: Ding, 2020 - - De novo - - - - - DNA SEQ-NG-I - WES TSC - PubMed: Ding, 2020 - - - - - - - - - 1 Yifeng Ding
+/. 15 c.1530_1531del r.(?) p.(Asp510Glufs*24) - - Unknown ACMG pathogenic (dominant) g.135781435_135781436del g.132906048_132906049del - - TSC1_000097 - PubMed: Ding, 2020 - - De novo - - - - - DNA SEQ - - TSC 2 PubMed: Ding, 2020 - M - China - - - - - 1 Yifeng Ding
Legend   How to query  

Assessment of functional consequences - Our conclusions on the functional consequences of variants are based on the type of variant, results of in vitro functional tests (doi: 10.1002/humu.21451; doi: 10.1002/humu.22202; doi: 10.1002/humu.23963), population frequencies, output from in silico splice site prediction algorithms, and any clinical/family data available to us. We also have output from protein prediction programs in this database for comparison purposes and they are not considered in our assessment of pathogenicity. PolyPhen Predictions - Note that these results are from PolyPhen-2 and only the HumDiv classification is shown.


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.